Skip to main content

Table 4 Allelic distribution of RAAS gene polymorphisms in gender

From: Analysis of renin-angiotensin aldosterone system gene polymorphisms in malaysian essential hypertensive and type 2 diabetic subjects

Alleles of RAAS Gene Polymorphisms

 

Group 1

Group 2

Group 3

Group 4

Male

Female

Male

Female

Male

Female

Male

Female

A6G

C

76

(78.40)

26

(21.60)

60

(90.90)

6

(9.10)

61

(76.25)

19

(23.75)

74

(94.87)

4

(5.13)

T

30

(89.50)

8

(10.50)

47

(87.04)

7

(12.96)

36

(65.45)

14

(25.45)

68

(94.44)

4

5.56)

p value

OR (95% CI)

0.662

0.78 (0.318–1.914)

0.563

1.49 (0.469–4.729)

0.680

1.25 (0.559–2.790)

1.000

1.09 (0.262–4.522)

A20C

A

82

(80.40)

20

(19.60)

55

(83.30)

11

(16.70)

70

(87.50)

10

(12.50)

67

(85.90)

11

(14.10)

C

31

(81.60)

7

(18.40)

41

(76.00)

13

(24.00)

39

(78.00)

11

(22.00)

60

(83.33)

12

(1.67)

p value

OR (95% CI)

1.000

0.93 (0.356–2.045)

0.363

1.59 (0.645–3.896)

0.220

1.97 (0.770–5.063)

0.821

1.22 (0.501–2.964)

MboI

(-)

85

(83.33)

17

(16.67)

58

(87.88)

8

(12.12)

66

(82.50)

14

(17.50)

65

(83.33)

13

(16.67)

(+)

29

(76.32)

9

(23.68)

44

(81.48)

10

(18.52)

43

(86.00)

7

(14.00)

65

(90.28)

7

(9.72)

p value

OR (95% CI)

0.339

1.55 (0.624–3.860)

0.442

1.65 (0.601–4.519)

0.635

0.77 (0.287–2.056)

0.238

0.54 (0.202–1.436)

Lys173Arg

Lys173

76 (74.51)

26 (25.49)

44 (66.70)

22 (33.30)

59 (73.75)

21 (26.25)

58 (74.36)

20 (25.64)

Arg173

29 (76.30)

9

(23.70)

37 (68.52)

17 (31.48)

39 (78.00)

11 (22.00)

53 (73.61)

19 (26.39)

p value

OR (95% CI)

1.000

0.90 (0.380–2.166)

0.847

0.92 (0.426–1.983)

0.678

0.79 (0.344–1.825)

1.000

1.04 (0.501–2.157)

Gly460Trp

Gly460

66

(64.71)

36

(35.29)

42

(63.64)

24

(36.36)

46

(57.50)

34

(42.50)

52

(69.30)

26

(30.70)

Trp460

19

(50.00)

19

(50.00)

35

(64.81)

19

(35.19)

23

(46.00)

27

(54.00)

44

(61.11)

28

(38.89)

p value

OR (95% CI)

0.124

1.88 (0.862–3.899)

0.893

0.95 (0.458–2.012)

0.201

1.59 (0.780–3.234)

0.479

1.27 (0.653–2.482)

  1. Data are reported as number of subjects with percent in parentheses, OR-odds ratio, CI – Confidence interval, Group 1- EHT, Group 2 -T2DM, Group 3- EHT+T2DM and Group 4-Control subjects, P value > 0.05 vs. Group 4.